Law360, New York (October 03, 2011, 2:41 PM ET) -- Pharmaceutical Product Development Inc. said Monday that private equity buyers The Carlyle Group LP and Hellman & Friedman LLC planned to take the profitable pharmaceutical industry contract research company private for $3.9 billion in a bid to boost its growth.
Carlyle and Hellman & Friedman will buy the Wilmington, N.C.-based company for $33.25 per share in cash, representing a per-share premium of 29.6 percent over the target's Sept. 30 closing price, PPD said.
PPD contracts with pharmaceutical, biotechnology, medical device, academic and government clients to perform drug...
Carlyle, Hellman To Take PPD Private For $3.9B
To view the full article, take a free trial now.
